2025Q4
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Pavilion Venture Partners LLC | 10% Owner | 4,481,153 | Mar 19, 2021 |
| Sirovich Matthew | 10% Owner | 2,730,297 | Nov 27, 2020 |
| Tasso Partners, LLC | — | 2,574,350 | Mar 14, 2025 |
| Greenspan Ira Scott | 10% Owner | 421,691 | Jun 11, 2018 |
| Aklog Lishan | CEO | 298,744 | Oct 2, 2025 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | Oct 2, 2025 | Sparks Ronald M | Director | Neutral | 90.0 | +150,000 | 230.77% | ✗ | - |
| Sep 30, 2025 | Oct 2, 2025 | White Debra | Director | Neutral | 90.0 | +150,000 | 230.77% | ✗ | - |
| Sep 30, 2025 | Oct 2, 2025 | Baxter Timothy E | Director | Neutral | 90.0 | +150,000 | 230.77% | ✗ | - |
| Sep 30, 2025 | Oct 2, 2025 | Glennon Michael J | Director | Neutral | 90.0 | +150,000 | 183.67% | ✗ | - |
| Sep 30, 2025 | Oct 2, 2025 | Agrawal Sundeep | Director | Neutral | 90.0 | +150,000 | 1230.01% | ✗ | - |
| Sep 30, 2025 | Oct 2, 2025 | Gordon Michael Adam | General Counsel | Neutral | 90.0 | +150,000 | 100.00% | ✗ | - |
| Sep 30, 2025 | Oct 2, 2025 | MCGRATH DENNIS M | CFO | Neutral | 90.0 | +150,000 | 295.08% | ✗ | - |
| Sep 30, 2025 | Oct 2, 2025 | Aklog Lishan | CEO | Neutral | 90.0 | +150,000 | 39.77% | ✗ | - |
| Sep 30, 2025 | Oct 2, 2025 | O'Neil Shaun | COO | Neutral | 90.0 | +150,000 | 836.45% | ✗ | - |
| Mar 14, 2025 | Tasso Partners, LLC | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 21, 2024 | Oct 23, 2024 | Agrawal Sundeep | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 19, 2024 | Sep 20, 2024 | Agrawal Sundeep | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 20, 2024 | Agrawal Sundeep | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 22, 2024 | Feb 23, 2024 | Baxter Timothy E | Director | Neutral | 90.0 | +65,000 | 100.00% | ✗ | - |
| Feb 22, 2024 | Feb 23, 2024 | White Debra | Director | Neutral | 90.0 | +65,000 | 100.00% | ✗ | - |
| Feb 22, 2024 | Feb 23, 2024 | Sparks Ronald M | Director | Neutral | 90.0 | +65,000 | 100.00% | ✗ | - |
| Feb 22, 2024 | Feb 23, 2024 | Harvey Joan B | Director | Neutral | 90.0 | +65,000 | 100.00% | ✗ | - |
| Feb 22, 2024 | Feb 23, 2024 | Glennon Michael J | Director | Neutral | 90.0 | +65,000 | 26.00% | ✗ | - |
| Feb 22, 2024 | Feb 23, 2024 | Cox James L | Director | Neutral | 90.0 | +65,000 | 100.00% | ✗ | - |
| May 4, 2022 | May 1, 2023 | O'Neil Shaun | COO | Sell | 46.3 | -25,935 | -8.90% | ✗ | $35.8K |
| May 1, 2023 | O'Neil Shaun | COO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 30, 2023 | Feb 2, 2023 | Sparks Ronald M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 30, 2023 | Feb 2, 2023 | White Debra | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 30, 2023 | Feb 2, 2023 | Harvey Joan B | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 30, 2023 | Feb 2, 2023 | Glennon Michael J | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 30, 2023 | Feb 2, 2023 | Cox James L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 30, 2023 | Feb 2, 2023 | Baxter Timothy E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 5, 2022 | Dec 7, 2022 | Glennon Michael J | Director | Buy | 95.0 | +250,000 | 403.23% | ✗ | $161K |
| Jun 7, 2022 | Jun 9, 2022 | Gordon Michael Adam | General Counsel | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 8, 2022 | Gordon Michael Adam | General Counsel | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 28, 2022 | Apr 11, 2022 | MCGRATH DENNIS M | CFO | Sell | 42.5 | -199,973 | -20.93% | ✗ | $236K |
| Mar 28, 2022 | Apr 11, 2022 | Aklog Lishan | CEO | Sell | 42.5 | -79,636 | -1.68% | ✗ | $94K |
| Feb 18, 2022 | Mar 1, 2022 | Baxter Timothy E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 15, 2021 | Mar 1, 2022 | Baxter Timothy E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 1, 2022 | Baxter Timothy E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 22, 2022 | Feb 24, 2022 | O'Neil Shaun | COO | Sell | 22.5 | -75,000 | -33.33% | ✗ | $182.3K |
| Feb 24, 2022 | O'Neil Shaun | COO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 18, 2022 | Feb 23, 2022 | Glennon Michael J | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 18, 2022 | Feb 23, 2022 | DeGuzman Brian J. | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 18, 2022 | Feb 23, 2022 | White Debra | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 18, 2022 | Feb 23, 2022 | Cox James L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 18, 2022 | Feb 23, 2022 | Sparks Ronald M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 18, 2022 | Feb 23, 2022 | MCGRATH DENNIS M | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 18, 2022 | Feb 23, 2022 | Aklog Lishan | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 11, 2022 | Feb 18, 2022 | Harvey Joan B | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 18, 2022 | Harvey Joan B | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 29, 2021 | May 3, 2021 | White Debra | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 3, 2021 | White Debra | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 1, 2021 | Apr 5, 2021 | Battleman David S. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 1, 2021 | Apr 5, 2021 | MCGRATH DENNIS M | CFO | Neutral | 90.0 | +150,000 | 18.62% | ✗ | - |
| Apr 1, 2021 | Apr 5, 2021 | Cox James L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 1, 2021 | Apr 5, 2021 | Glennon Michael J | Chair | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 1, 2021 | Apr 5, 2021 | Sparks Ronald M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 1, 2021 | Apr 5, 2021 | Weild IV David | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 1, 2021 | Apr 5, 2021 | DeGuzman Brian J. | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 1, 2021 | Apr 5, 2021 | Aklog Lishan | CEO | Neutral | 82.5 | +150,000 | 2.68% | ✗ | - |
| Mar 18, 2021 | Mar 19, 2021 | Aklog Lishan | CEO | Buy | 56.3 | +7,500 | 0.13% | ✗ | $32.3K |
| Nov 24, 2020 | Nov 27, 2020 | SIROVICH MATTHEW | 10% Owner | Sell | 22.5 | -86,239 | -2.83% | ✗ | $170.9K |
| Nov 18, 2020 | Nov 20, 2020 | SIROVICH MATTHEW | 10% Owner | Sell | 22.5 | -100,000 | -3.17% | ✗ | $181.6K |
| May 28, 2020 | Jun 1, 2020 | SIROVICH MATTHEW | 10% Owner | Sell | 20.0 | -200,921 | -5.99% | ✗ | $403.1K |
| Apr 30, 2020 | May 4, 2020 | Weild IV David | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 30, 2020 | May 4, 2020 | Sparks Ronald M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 30, 2020 | May 4, 2020 | Glennon Michael J | Chair | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 30, 2020 | May 4, 2020 | DeGuzman Brian J. | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 30, 2020 | May 4, 2020 | Cox James L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 30, 2020 | May 4, 2020 | Battleman David S. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 30, 2020 | May 4, 2020 | Aklog Lishan | CEO | Neutral | 82.5 | +250,000 | 4.69% | ✗ | - |
| Apr 30, 2020 | May 4, 2020 | MCGRATH DENNIS M | CFO | Neutral | 90.0 | +250,000 | 46.15% | ✗ | - |
| Jan 30, 2020 | Feb 3, 2020 | SIROVICH MATTHEW | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 24, 2019 | May 28, 2019 | MCGRATH DENNIS M | CFO | Buy | 67.5 | +5,000 | 0.95% | ✗ | $5.4K |
| May 23, 2019 | May 28, 2019 | Aklog Lishan | CEO | Buy | 68.8 | +30,000 | 0.57% | ✗ | $32.9K |
| Mar 15, 2019 | Mar 19, 2019 | Aklog Lishan | CEO | Neutral | 82.5 | +200,000 | 3.92% | ✗ | - |
| Mar 15, 2019 | Mar 19, 2019 | MCGRATH DENNIS M | CFO | Neutral | 90.0 | +500,000 | 2083.33% | ✗ | - |
| Mar 7, 2019 | Mar 12, 2019 | Cox James L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 7, 2019 | Mar 12, 2019 | Battleman David S. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 7, 2019 | Mar 11, 2019 | Glennon Michael J | Chair | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 7, 2019 | Mar 11, 2019 | Sparks Ronald M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 7, 2019 | Mar 11, 2019 | DeGuzman Brian J. | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 7, 2019 | Mar 11, 2019 | Weild IV David | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 12, 2018 | Feb 4, 2019 | MCGRATH DENNIS M | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 27, 2018 | Jan 28, 2019 | SIROVICH MATTHEW | 10% Owner | Neutral | 90.0 | +332,400 | 27.73% | ✗ | - |
| Aug 28, 2018 | Aug 28, 2018 | Aklog Lishan | CEO | Buy | 68.8 | +30,000 | 0.59% | ✗ | $35.4K |
| Jun 26, 2018 | Jul 12, 2018 | DeGuzman Brian J. | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 26, 2018 | Jul 11, 2018 | Glennon Michael J | Chair | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 12, 2018 | Jul 11, 2018 | Aklog Lishan | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 25, 2018 | SIROVICH MATTHEW | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 8, 2018 | Jun 11, 2018 | Greenspan Ira Scott | 10% Owner | Sell | 26.3 | -18,300 | -4.16% | ✗ | $19K |
| Jun 1, 2018 | Jun 5, 2018 | Greenspan Ira Scott | 10% Owner | Sell | 20.0 | -532,255 | -54.74% | ✗ | $516.3K |
| Apr 5, 2018 | Apr 9, 2018 | Aklog Lishan | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 14, 2018 | Feb 16, 2018 | Sparks Ronald M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 14, 2018 | Feb 16, 2018 | Cox James L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 14, 2018 | Feb 16, 2018 | Battleman David S. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 14, 2018 | Feb 16, 2018 | Weild IV David | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 14, 2018 | Feb 16, 2018 | Glennon Michael J | Chair | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 14, 2018 | Feb 16, 2018 | DeGuzman Brian J. | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 2, 2018 | Feb 16, 2018 | Aklog Lishan | CEO | Neutral | 37.5 | -34,153 | -0.67% | ✗ | - |
| Feb 14, 2018 | Feb 16, 2018 | MCGRATH DENNIS M | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 22, 2017 | Feb 14, 2018 | Aklog Lishan | CEO | Neutral | 27.5 | -3,858,524 | -43.06% | ✗ | - |
| Dec 21, 2017 | Feb 14, 2018 | Greenspan Ira Scott | Director | Neutral | 27.5 | -5,045,578 | -69.89% | ✗ | - |
| Dec 21, 2017 | Jan 3, 2018 | DeGuzman Brian J. | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |